Louisiana State Employees Retirement System cut its holdings in shares of Davita Inc (NYSE:DVA) by 9.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,400 shares of the company’s stock after selling 800 shares during the period. Louisiana State Employees Retirement System’s holdings in Davita were worth $530,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in DVA. OppenheimerFunds Inc. lifted its stake in Davita by 58.7% during the second quarter. OppenheimerFunds Inc. now owns 4,066,317 shares of the company’s stock worth $282,365,000 after purchasing an additional 1,504,347 shares during the last quarter. Investec Asset Management LTD increased its holdings in shares of Davita by 114.5% during the second quarter. Investec Asset Management LTD now owns 986,777 shares of the company’s stock worth $68,522,000 after buying an additional 526,847 shares in the last quarter. Glenmede Trust Co. NA increased its holdings in shares of Davita by 921.3% during the second quarter. Glenmede Trust Co. NA now owns 337,764 shares of the company’s stock worth $23,454,000 after buying an additional 304,693 shares in the last quarter. Morgan Stanley increased its holdings in shares of Davita by 46.9% during the second quarter. Morgan Stanley now owns 946,208 shares of the company’s stock worth $65,704,000 after buying an additional 302,027 shares in the last quarter. Finally, United Services Automobile Association increased its holdings in shares of Davita by 462.6% during the second quarter. United Services Automobile Association now owns 265,692 shares of the company’s stock worth $48,754,000 after buying an additional 218,464 shares in the last quarter. Hedge funds and other institutional investors own 87.62% of the company’s stock.

Several research analysts have recently issued reports on the stock. ValuEngine upgraded shares of Davita from a “hold” rating to a “buy” rating in a report on Tuesday, October 9th. Zacks Investment Research upgraded shares of Davita from a “hold” rating to a “buy” rating and set a $78.00 price target for the company in a report on Monday, July 9th. Finally, JPMorgan Chase & Co. upgraded shares of Davita from an “underweight” rating to a “neutral” rating in a report on Thursday, September 13th. Five analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. Davita presently has a consensus rating of “Buy” and a consensus price target of $82.50.

Shares of NYSE:DVA opened at $67.65 on Friday. The firm has a market cap of $11.51 billion, a PE ratio of 18.00, a P/E/G ratio of 0.88 and a beta of 1.09. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.90 and a quick ratio of 1.88. Davita Inc has a 52-week low of $52.51 and a 52-week high of $80.71.

Davita (NYSE:DVA) last announced its quarterly earnings results on Wednesday, August 1st. The company reported $1.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.97 by $0.08. The company had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.88 billion. Davita had a net margin of 4.30% and a return on equity of 14.49%. The company’s revenue for the quarter was up 6.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.92 earnings per share. On average, sell-side analysts anticipate that Davita Inc will post 4 EPS for the current year.

Davita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Recommended Story: Day Trading

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).

Institutional Ownership by Quarter for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.